Piramal Pharma advanced 2.69% to Rs 154.35 after the pharmaceutical company reported a consolidated net profit surged 102.1% to Rs 101.27 crore in Q4 FY24 as against Rs 50.11 crore posted in Q4 FY23. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
